CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Market Closed - Nyse Other stock markets 21:00:02 20/06/2025 BST			5-day change	1st Jan Change
147.45 ^USD	+1.49%		-1.34%	-20.12%

06-19	Charles River Laboratories International, Inc., Q1 2025 Earnings Call, May 07, 2025
06-09	Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:00 AM

Charles River Laboratories International, Inc., Q1 2024 Earnings Call, May 09, 2024

Published on 09/05/2024 at 13:30

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories First Quarter 2024 Earnings Conference Call. This call

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., Q1 2025 Earnings Call, May 07, 2025	06-19
Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:00 AM	06-09
Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10:30 AM	06-04
Charles River Laboratories International to Seek Strategic M&A	06-03	CI
Charles River Laboratories, CHDI Foundation Extend Collaboration	05-28	MT
Charles River Laboratories International Extend Drug Discovery Partnership With CHDI Foundation	05-28	RE
Charles River Laboratories International CEO James C. Foster's Employment Extended Until February 2027 - SEC Filing	05-23	RE
Declaration of Voting Results by Charles River Laboratories International	05-23	CI
Trump's Tariff Blitz Roils Markets, Targets EU and Apple	05-23
Redburn Atlantic Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $182 From $188	05-23	MT
Analyst recommendations: Crowdstrike, AMD, Boeing, Intuit, Okta…	05-23
Charles River Laboratories International, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08:40 AM	05-14
TD Cowen Upgrades Charles River Laboratories International to Buy From Hold, Adjusts PT to $179 From $105	05-14	MT
Morgan Stanley Cuts Price Target on Charles River Laboratories International to $168 From $184	05-09	MT
UBS Cuts Price Target on Charles River Laboratories International to $150 From $185, Keeps Neutral Rating	05-08	MT
Barclays Adjusts Price Target on Charles River Laboratories International to $155 From $145, Maintains Equalweight Rating	05-08	MT
Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $180 From $140, Maintains Buy Rating	05-08	MT
London Calling: Markets Jump	05-08
Jefferies Adjusts Price Target on Charles River Laboratories International to $142 From $100, Maintains Hold Rating	05-08	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $145 From $165, Maintains Neutral Rating	05-08	MT
Citigroup Adjusts Price Target on Charles River Laboratories International to $150 From $175, Maintains Neutral Rating	05-08	MT
Deutsche Bank Adjusts Charles River Laboratories International Price Target to $180 From $140, Maintains Buy Rating	05-08	MT
Evercore ISI Upgrades Charles River Laboratories International to Outperform From In Line, Adjusts PT to $170 From $235	05-08	MT
Analyst recommendations: AMD, Walt Disney, Applovin, Ionq, Uber...	05-08
Equity Markets Close Higher as Fed Decides to Keep Fund Rates Unchanged	05-07	MT